Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system ...

Israeli bombardment killed hundreds of people in Gaza, Palestinian health authorities said on Tuesday (March 18), threatening ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars. Ciara Lee reports. Rome marathon runners pause in silence for Pope ...

The round will fund a “one-and-done” treatment for a rare kidney condition that its CEO says can address concerns patients ...

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a cash infusion to head to clinical trials.

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price. Also ...

The Senate on Monday confirmed former Rep. Lori Chavez-DeRemer (R-Ore.) to lead the Department of Labor, cementing another of President Trump’s nominees in bipartisan fashion. Senators voted 67 ...

Sun Pharmaceutical Industries Limited on Monday announced that it will acquire Checkpoint, an immunotherapy and targeted oncology company. According to the company’s exchange filing, Checkpoint ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inozyme Pharma (INZY – Research Report) and Urogen Pharma (URGN – Research Report) with bullish ...

It is aimed at stopping terrorism and radicalisation, but devastating attacks and high-profile reviews have meant Prevent has been under scrutiny since it started. The government programme has ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Inozyme Pharma (INZY – Research Report). The company’s shares opened today at $1.14. Effectively assess a stock ...